Directed evolution builds nanoparticles

The 2018 Nobel Prize in Chemistry went to three scientists who developed the method that forever changed protein engineering: directed evolution. Mimicking natural evolution, directed evolution guides the synthesis of proteins ...

Chemists harness power of light to tackle asymmetrical molecules

No, molecules do not actually have hands. But scientists refer to them in this way when looking at asymmetric molecules that are mirror images of one another and therefore are not superimposable. Whether a molecule is a "lefty" ...

Researchers image atomic structure of important immune regulator

A new study by investigators from Brigham and Women's Hospital provides a biophysical and structural assessment of a critical immune regulating protein called human T-cell immunoglobulin and mucin domain containing protein-3 ...

A banner year for pharma

As 2018 draws to a close, the pharmaceutical industry is celebrating a prosperous year of new investments and therapeutic breakthroughs. These successes were driven by cutting-edge science and progress in finally translating ...

New possible target for treating major common diseases

There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. ...

Peptide exploits Achilles' heel of Zika virus

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have engineered an antiviral peptide that exploits the Zika virus at its Achilles' heel—the viral membrane—hence stopping the virus from causing ...

Adaptive behavior, markets, and what it means for curing cancer

MIT Sloan finance professor Andrew Lo is working to solve global issues through his studies of financial markets. He's also applying his research on risk to a problem that's not quite as conventional for a financial scholar: ...

page 2 from 9